Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Platinum Chemoradiation in TNBC
NCT01167192Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2011
- Primary completion
- Aug 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, carboplatin in triple-negative breast cancer (TNBC), sponsored by Washington University School of Medicine. Started Feb 2011; status: terminated.
02
Drugs
cisplatincarboplatin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01167192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167192.